Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
New Technology Makes Tumor Eliminate Itself
A new technology developed by UZH researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed.
Vitamin B3 as a possible treatment for glaucoma
Glaucoma involves a high risk of losing sight.
U.S. administers 273.5 mln doses of COVID-19 vaccines - CDC
The United States has administered 273,545,207 doses of COVID-19 vaccines in the country as of Sunday morning and distributed 344,503,495 doses, the U.
Biogen’s inherited eye disease gene therapy misses primary endpoint
A gene therapy developed by Biogen for the rare inherited eye disease X-linked retinitis pigmentosa (XLRP) has failed to meet the primary endpoint in a Phase II/III study.
Sanofi, GSK’s COVID-19 vaccine achieves positive Phase II results
Sanofi and GlaxoSmithKline (GSK) have reported that their COVID-19 vaccine generates strong immune responses across all adult age groups.
Lilly buys into MiNA’s protein-boosting RNA tech in $1.25bn deal
UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform, which upregulates the activity of proteins, with Eli Lilly the latest to ge...
Pfizer says 'good reason' to believe in success of anti-viral drug
ATHENS (Reuters) - The chief executive of Pfizer Inc said on Friday he had “very good reason” to believe in the success of an oral COVID-19 antiviral therapy by the drugmaker now in an ear...
Drug R&D innovation reshaping manufacturing and the CDMO sector
Our virtual CPHI Discover event (17th-28th May) is just around the corner, full to the brim with three main content tracks.
Scientists design new drug compound to stop malaria in its tracks
Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle...
Sanofi hit with charges of 'widespread' email deletion in legal saga stemming from Zantac recalls
The popular heartburn med Zantac officially exited U.
Women who drink 2 sodas a day have a higher risk of developing colorectal cancer before they reach 50, study finds
Daily consumption of sodas and other sweetened drinks may be linked to an increased risk of developing colorectal cancer before age 50, according to a study published May 6 in the journal Gut.
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
SAN DIEGO, May 13, 2021 /PRNewswire/ -- Heron Therapeutics, Inc.
250
251
252
253
254
255
256
257
258
